ABSTRACT
In 94 patients with large myocardial infarction, their coronary venous blood flow was studied in the acute period of the disease by continuous coronary sinus thermodilution. No relationship was established between the coronary venous blood flow and the duration of coronary heart disease. The patients with anterior myocardial infarction had a significantly less blood flow in the vena cordis magna than those with posterolateral infarction. No correlation was found between the blood flow and precordial mapping parameters. Thus, continuous coronary sinus thermodilution cannot be used for indirect identification of the site of myocardial infarction and for prediction of its progression severity.
Subject(s)
Coronary Circulation/physiology , Coronary Vessels/physiopathology , Myocardial Infarction/physiopathology , Adult , Aged , Female , Humans , Male , Middle Aged , Regional Blood Flow , Thermodilution , Time Factors , Veins/physiopathologyABSTRACT
A total of 85 patients (68 with coronary heart disease in the presence of effort angina of various functional classes (a major group) and 17 with neurocirculatory++ dystonia and cardialgic syndrome (a control group)) were examined. Heart failure severity and blood flow distribution in the functioning myocardial areas were evaluated in transient ischemia induced by atrial pacing. Three levels of coronary venous blood flow were defined in patients with coronary heart disease. A relationship between the coronary blood flow, disease history duration, and coronary blood flow changes was examined in cardioselective exercise.
Subject(s)
Cardiac Pacing, Artificial , Coronary Circulation/physiology , Coronary Disease/physiopathology , Coronary Vessels/physiopathology , Veins/physiopathology , Adult , Aged , Coronary Disease/etiology , Exercise Test , Heart Atria/physiopathology , Hemodynamics/physiology , Humans , Male , Middle AgedSubject(s)
Butylated Hydroxytoluene/pharmacology , Coronary Disease/drug therapy , Hemodynamics/drug effects , Myocardium/metabolism , Adult , Butylated Hydroxytoluene/therapeutic use , Coronary Circulation/drug effects , Coronary Disease/metabolism , Coronary Disease/physiopathology , Humans , Lipid Peroxidation/drug effects , Male , Middle AgedABSTRACT
Blood catecholamines (dopamine, adrenaline and noradrenaline) were measured in the coronary sinus and artery of 35 patients divided into 2 groups: coronary patients with stable angina of effort, functional class II-III (group 1) and patients with NCD (group 2), before and during a cardioselective load test (atrial stimulation). Developing myocardial ischemia was associated with a significant rise of noradrenaline in arterial and coronary venous blood. The use of isoptin changed noradrenaline balance, resulting in increased noradrenaline level in the coronary sinus, while coronary flow increased, as did the anginal threshold. Noradrenaline rise may well be an additional antianginal factor mediating the action of isoptin.
Subject(s)
Coronary Disease/drug therapy , Dopamine/blood , Epinephrine/blood , Norepinephrine/blood , Verapamil/therapeutic use , Adult , Arteries , Coronary Disease/blood , Coronary Vessels , Humans , Male , Middle Aged , Stimulation, Chemical , VeinsABSTRACT
Single intravenous doses of isoptin (10 mg) and obsidan (5 mg) were tested for their effects on hemodynamic and coronary blood flow parameters in 35 patients with coronary heart disease and functional classes II-III angina pectoris of effort. In most cases, hemodynamic and coronary blood flow responses to the drug administered were found to be identical. It was concluded that isoptin was effective as an antianginal agent in eukinetic hemodynamics, obsidan, in hyperkinetic one.
Subject(s)
Angina Pectoris/drug therapy , Calcium Channel Blockers/therapeutic use , Coronary Circulation/drug effects , Hemodynamics/drug effects , Propranolol/therapeutic use , Verapamil/therapeutic use , Adult , Angina Pectoris/physiopathology , Calcium Channel Blockers/administration & dosage , Clinical Trials as Topic , Humans , Infusions, Intravenous , Male , Middle Aged , Propranolol/administration & dosageABSTRACT
Changes in the rate of coronary venous flow through the affected area under the effect of intravenous jet injections of propranolol, 0.1 mg per 1 kg body weight, were assessed in 18 patients of the hyperkinetic central hemodynamic type during acute myocardial infarction. In the first group of patients, whose mean flow rate through the affected wall was 106.2 +/- 5.7 ml/min, the latter parameter decreased in proportion to the drop in double product. In the second group of patients, whose coronary venous flow rate was reduced (51.4 +/- 6.9 ml/min), propranolol-induced drop in the flow rate was less marked, as compared to the drop in double product. It was correlated with dramatically depressed pumping function of the heart.
Subject(s)
Coronary Circulation/drug effects , Myocardial Infarction/drug therapy , Neurocirculatory Asthenia/drug therapy , Propranolol/therapeutic use , Adult , Drug Evaluation , Hemodynamics/drug effects , Humans , Male , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/physiopathology , Neurocirculatory Asthenia/etiology , Neurocirculatory Asthenia/physiopathology , Time FactorsABSTRACT
A new thrombolytic drug, renokinase, was administered intravenously to 30 patients with macrofocal myocardial infarction (MI), admitted to hospital within early hours of its onset. Changes in the venous network of the heart were assessed, using continuous thermodilution, in the presence of thrombolytic treatment. Coronary venous flow was shown to increase by 20% and more in 17 patients, more than 30% in 15 patients, and more than 40% in 10. Low MI was associated with a significant increase of blood flow rate in the coronary sinus as well as other cardiac veins, while anterior MI was associated with flow rate increase in the coronary sinus only. A 20-30% increase in any of the coronary flow parameters limited the necrosis focus, as evidenced by precordial mapping from 35 ECG leads. Renokinase (60,000 units) was well tolerated by the patients.
Subject(s)
Coronary Circulation/drug effects , Myocardial Infarction/drug therapy , Urokinase-Type Plasminogen Activator/administration & dosage , Adult , Aged , Coronary Vessels , Female , Humans , Injections, Intravenous , Male , Middle Aged , Myocardial Infarction/physiopathology , Urokinase-Type Plasminogen Activator/therapeutic useABSTRACT
Variations in arterial and venous blood prostacyclin and thromboxane were examined in 32 patients with coronary heart disease, neurocirculatory dystonia and the cardialgic syndrome, exposed to cardioselective stress as a result of the atrial stimulation test. Prostacyclin and thromboxane measurement in blood specimens obtained from the left ventricle and the coronary venous network may provide additional markers of myocardial ischemia in cases where diagnosis is otherwise difficult to make.
Subject(s)
Coronary Vessels , Epoprostenol/blood , Myocardial Infarction/blood , Thromboxane A2/blood , Adult , Humans , Male , Middle AgedABSTRACT
Intracardiac electrophysiologic studies were carried out in 41 patients with paroxysmal supraventricular tachycardias. Reciprocal atrioventricular tachycardia due to dissociated conduction through the atrioventricular junction was diagnosed in 29 patients. Electrophysiologic data suggested trifascicular atrioventricular conduction in 4 patients, and quadrifascicular conduction in 2. A concept of polyfascicular impulse conduction through the atrioventricular junction in some cases of reciprocal nodal tachycardia is proposed. It is demonstrated that combinations of congenital cardiac conduction abnormalities may be possible in the same individual.
Subject(s)
Atrioventricular Node/physiopathology , Heart Conduction System/physiopathology , Tachycardia, Atrioventricular Nodal Reentry/physiopathology , Tachycardia, Supraventricular/physiopathology , Adolescent , Adult , Cardiac Catheterization , Cardiac Pacing, Artificial , Electrocardiography , Female , Humans , Male , Middle AgedABSTRACT
The concealed Wolff-Parkinson-White (WPW) syndrome, the electrophysiologic and morphologic basis of cardiac arrhythmias, was shown to be a cause of the attacks of supraventricular tachycardia. The latter is rooted in the concealed WPW syndrome in about 30% of patients showing no electrocardiographic signs of pre-excitation. Electrophysiologic criteria of the diagnosis of supraventricular tachycardias due to the concealed WPW syndrome are listed. Concealed Kent's bundle was most commonly found on the left side. As regards antiarrhythmic therapy, disopyramide is one of the most effective drugs for patients with supraventricular tachycardias due to the concealed WPW syndrome.
Subject(s)
Tachycardia, Paroxysmal/etiology , Wolff-Parkinson-White Syndrome/complications , Action Potentials , Adolescent , Adult , Anti-Arrhythmia Agents/therapeutic use , Electrocardiography , Female , Heart Conduction System/physiopathology , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Tachycardia, Paroxysmal/diagnosis , Tachycardia, Paroxysmal/drug therapy , Wolff-Parkinson-White Syndrome/diagnosis , Wolff-Parkinson-White Syndrome/physiopathologyABSTRACT
To study the hemodynamic and metabolic effects of isoptin, the drug was infused intravenously to 15 patients with acute transmural myocardial infarction at a dosage of 0.13-0.17 mg per kg bw. Along with the parameters of the central hemodynamics and the myocardial contractility of the left ventricle, using extraction coefficients the authors determined some parameters of myocardial metabolism. The drug was well tolerated by the patients, virtually did not affect the parameters of myocardial contractility, decreased the work of the heart at the expense of a significant reduction of the after-load and lowered manifestations of the ischemia of the intact myocardium (the coefficient of lactate extraction by the myocardium was found to elevate).